129 related articles for article (PubMed ID: 34999590)
1. Significance of Patient-Reported Outcomes for Metastatic Breast Cancer Patients.
Hillebrand LE; Söling U; Marschner N
Oncol Res Treat; 2022; 45(7-8):423-429. PubMed ID: 34999590
[TBL] [Abstract][Full Text] [Related]
2. Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial.
Harbeck N; Iyer S; Turner N; Cristofanilli M; Ro J; André F; Loi S; Verma S; Iwata H; Bhattacharyya H; Puyana Theall K; Bartlett CH; Loibl S
Ann Oncol; 2016 Jun; 27(6):1047-1054. PubMed ID: 27029704
[TBL] [Abstract][Full Text] [Related]
3. Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications.
Stefanovic S; Wallwiener M; Karic U; Domschke C; Katic L; Taran FA; Pesic A; Hartkopf A; Hadji P; Teufel M; Schuetz F; Sohn C; Fasching P; Schneeweiss A; Brucker S
Support Care Cancer; 2017 Feb; 25(2):549-558. PubMed ID: 27747478
[TBL] [Abstract][Full Text] [Related]
4. Chinese multicentre prospective registry of breast cancer patient-reported outcome-reconstruction and oncoplastic cohort (PRO-ROC): a study protocol.
Li L; Yang B; Li H; Yin J; Jin F; Han S; Liao N; Shi J; Ling R; Li Z; Ouyang L; Wang X; Fu P; Ouyang Z; Ma B; Wu X; Wang H; Liu J; Shao Z; Wu J
BMJ Open; 2019 Dec; 9(12):e032945. PubMed ID: 31843846
[TBL] [Abstract][Full Text] [Related]
5. Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR).
Mercieca-Bebber R; Williams D; Tait MA; Roydhouse J; Busija L; Sundaram CS; Wilson M; Langford A; Rutherford C; Roberts N; King M; Vodicka E; Devine B;
Qual Life Res; 2018 Oct; 27(10):2581-2591. PubMed ID: 29915979
[TBL] [Abstract][Full Text] [Related]
6. PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients-study protocol for a randomised controlled trial.
Karsten MM; Kühn F; Pross T; Blohmer JU; Hage AM; Fischer F; Rose M; Grittner U; Gebert P; Ferencz J; Pauler L; Breidenbach C; Kowalski C;
Trials; 2021 Sep; 22(1):666. PubMed ID: 34583744
[TBL] [Abstract][Full Text] [Related]
7. Progression-free survival and quality of life in metastatic breast cancer: The patient perspective.
Mertz S; Benjamin C; Girvalaki C; Cardone A; Gono P; May SG; Comerford E; Than KS; Birch K; Roach M; Myers S; Sasane M; Lavi L; Cameron A; Cardoso F
Breast; 2022 Oct; 65():84-90. PubMed ID: 35870420
[TBL] [Abstract][Full Text] [Related]
8. An analysis from the Quality Outcomes Database, Part 1. Disability, quality of life, and pain outcomes following lumbar spine surgery: predicting likely individual patient outcomes for shared decision-making.
McGirt MJ; Bydon M; Archer KR; Devin CJ; Chotai S; Parker SL; Nian H; Harrell FE; Speroff T; Dittus RS; Philips SE; Shaffrey CI; Foley KT; Asher AL
J Neurosurg Spine; 2017 Oct; 27(4):357-369. PubMed ID: 28498074
[TBL] [Abstract][Full Text] [Related]
9. A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application.
Richardson D; Zhan L; Mahtani R; McRoy L; Mitra D; Reynolds M; Odom D; Hollis K; Kaye JA; Jones C; Hargis J
Breast Cancer Res Treat; 2021 May; 187(1):113-124. PubMed ID: 33428072
[TBL] [Abstract][Full Text] [Related]
10. Measuring Quality of Life Using Patient-Reported Outcomes in Real-World Metastatic Breast Cancer Patients: The Need for a Standardized Approach.
Clarijs ME; Thurell J; Kühn F; Uyl-de Groot CA; Hedayati E; Karsten MM; Jager A; Koppert LB
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065805
[TBL] [Abstract][Full Text] [Related]
11. Final Effectiveness and Safety Results of NABUCCO: Real-World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab-Paclitaxel.
Marschner N; Salat C; Söling U; Hansen R; Grebhardt S; Harde J; Nusch A; Potthoff K
Clin Breast Cancer; 2018 Dec; 18(6):e1323-e1337. PubMed ID: 30100104
[TBL] [Abstract][Full Text] [Related]
12. The use of patient-reported outcomes in advanced breast cancer clinical trials: a review of the published literature.
Turner-Bowker DM; Hao Y; Foley C; Galipeau N; Mazar I; Krohe M; Globe D; Shields AL
Curr Med Res Opin; 2016 Oct; 32(10):1709-17. PubMed ID: 27331272
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
[TBL] [Abstract][Full Text] [Related]
14. Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry.
Müller V; Nabieva N; Häberle L; Taran FA; Hartkopf AD; Volz B; Overkamp F; Brandl AL; Kolberg HC; Hadji P; Tesch H; Ettl J; Lux MP; Lüftner D; Belleville E; Fasching PA; Janni W; Beckmann MW; Wimberger P; Hielscher C; Fehm TN; Brucker SY; Wallwiener D; Schneeweiss A; Wallwiener M
Breast; 2018 Feb; 37():154-160. PubMed ID: 29237546
[TBL] [Abstract][Full Text] [Related]
15. Patient-Reported Outcomes in Pediatric Patients With Cancer.
Reeve BB; Greenzang KA; Sung L
Am Soc Clin Oncol Educ Book; 2023 May; 43():e390272. PubMed ID: 37172266
[TBL] [Abstract][Full Text] [Related]
16. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer.
Wagner AD; Thomssen C; Haerting J; Unverzagt S
Cochrane Database Syst Rev; 2012 Jul; (7):CD008941. PubMed ID: 22786517
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of Patient-Reported Outcomes Measurement Information System to assess quality of life among patients with breast cancer initiating care at an academic center.
Matthys MB; Dempsey AM; Melisko ME; Dreher N; Che ML; Van't Veer LJ; Esserman LJ; Basu A
Cancer; 2021 Jul; 127(13):2342-2349. PubMed ID: 33957704
[TBL] [Abstract][Full Text] [Related]
18. Rare use of patient-reported outcomes in childhood cancer clinical trials - a systematic review of clinical trial registries.
Riedl D; Rothmund M; Darlington AS; Sodergren S; Crazzolara R; de Rojas T;
Eur J Cancer; 2021 Jul; 152():90-99. PubMed ID: 34090144
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
Ferreira AR; Di Meglio A; Pistilli B; Gbenou AS; El-Mouhebb M; Dauchy S; Charles C; Joly F; Everhard S; Lambertini M; Coutant C; Cottu P; Lerebours F; Petit T; Dalenc F; Rouanet P; Arnaud A; Martin A; Berille J; Ganz PA; Partridge AH; Delaloge S; Michiels S; Andre F; Vaz-Luis I
Ann Oncol; 2019 Nov; 30(11):1784-1795. PubMed ID: 31591636
[TBL] [Abstract][Full Text] [Related]
20. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
